What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His main research concerns Breast cancer, Pathology, Internal medicine, Oncology and Tissue microarray.
Torsten O. Nielsen is involved in the study of Breast cancer that focuses on Tamoxifen in particular.
His Pathology study incorporates themes from Multivariate analysis and Gene expression profiling.
His research in Estrogen receptor, Cancer, Progesterone receptor, PAM50 Gene Expression Signature and Odds ratio are components of Internal medicine.
His biological study spans a wide range of topics, including Basal, Tumor-infiltrating lymphocytes, MammaPrint, Gynecology and Biomarker.
His Tissue microarray research incorporates themes from Stromal cell, Fibromatosis, Breast carcinoma and Synovial sarcoma.
His most cited work include:
- Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. (2910 citations)
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes (2823 citations)
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (2142 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Pathology and Cancer.
His Breast cancer research includes themes of Biomarker, Cancer research and Basal.
Torsten O. Nielsen combines subjects such as Gynecology, Chemotherapy, Cohort and Clinical trial with his study of Oncology.
His study connects Gene expression profiling and Pathology.
His Cancer research is multidisciplinary, incorporating elements of Carcinoma and Bioinformatics.
The concepts of his Tissue microarray study are interwoven with issues in Survival rate and Breast carcinoma.
He most often published in these fields:
- Breast cancer (56.27%)
- Internal medicine (45.48%)
- Oncology (44.02%)
What were the highlights of his more recent work (between 2016-2021)?
- Breast cancer (56.27%)
- Internal medicine (45.48%)
- Oncology (44.02%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Breast cancer, Internal medicine, Oncology, Cancer research and Cancer.
The various areas that Torsten O. Nielsen examines in his Breast cancer study include Immunohistochemistry, Tissue microarray, Pathology and Hazard ratio.
His Oncology study combines topics from a wide range of disciplines, such as Clinical trial, Chemotherapy, Tumor-infiltrating lymphocytes, Biomarker and Triple-negative breast cancer.
His Cancer research research is multidisciplinary, incorporating perspectives in Immune checkpoint, Immune system, Immunotherapy and Sarcoma, Synovial sarcoma.
His work in the fields of Cancer, such as Tamoxifen, intersects with other areas such as MSH2.
His Estrogen receptor research is multidisciplinary, incorporating perspectives in Gene expression profiling and Gene, Somatic cell.
Between 2016 and 2021, his most popular works were:
- Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors (224 citations)
- Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research (190 citations)
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer (133 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Breast cancer, Internal medicine, Oncology, Cancer research and Tumor-infiltrating lymphocytes.
His Breast cancer research focuses on subjects like Hazard ratio, which are linked to Mastectomy.
His Oncology research includes themes of Stromal tumor, Clinical trial and Chemotherapy.
His work deals with themes such as Immune checkpoint, EGR1, Sarcoma, Synovial sarcoma and Phosphorylation, which intersect with Cancer research.
His Tumor-infiltrating lymphocytes study also includes fields such as
- Biomarker, which have a strong connection to Immunotherapy,
- PD-L1 and related Estrogen receptor negative and Immunohistochemistry.
The Cancer study combines topics in areas such as Antibody and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
